Obliterating bronchiolitis in a patient treated with (D)-penicillamine

Arch Bronconeumol. 2013 Sep;49(9):411-2. doi: 10.1016/j.arbres.2013.02.002. Epub 2013 Apr 10.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Bronchiolitis Obliterans / chemically induced*
  • Bronchiolitis Obliterans / diagnostic imaging
  • Bronchiolitis Obliterans / drug therapy
  • Bronchiolitis Obliterans / pathology
  • Bronchiolitis Obliterans / surgery
  • Bronchodilator Agents / therapeutic use
  • Chelating Agents / adverse effects*
  • Chelating Agents / therapeutic use
  • Chelation Therapy / adverse effects
  • Combined Modality Therapy
  • Copper
  • Dyslipidemias / complications
  • Dyslipidemias / drug therapy
  • Graves Disease / complications
  • Graves Disease / radiotherapy
  • Hepatolenticular Degeneration / complications
  • Hepatolenticular Degeneration / drug therapy*
  • Humans
  • Hypertension / complications
  • Hypertension / drug therapy
  • Lung Transplantation
  • Male
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • Oxygen Inhalation Therapy
  • Penicillamine / adverse effects*
  • Penicillamine / therapeutic use
  • Respiratory Insufficiency / etiology
  • Respiratory Insufficiency / therapy
  • Tomography, X-Ray Computed

Substances

  • Bronchodilator Agents
  • Chelating Agents
  • Copper
  • Penicillamine
  • Methylprednisolone